Charles Schwab Investment Management Inc X Biotech Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 58,437 shares of XBIT stock, worth $389,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,437

Previous 54,139 7.94%

Holding current value

$389,190

Previous $278,000 62.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.55 - $7.95 $23,853 - $34,169	4,298 Added 7.94%	58,437 $451,000
Q2 2024 Aug 12, 2024	BUY	$4.54 - $9.89 $198,225 - $431,817	43,662 Added 416.74%	54,139 $278,000
Q2 2022 Aug 15, 2022	SELL	$5.13 - $9.2 $175,528 - $314,787	-34,216 Reduced 76.56%	10,477 $59,000
Q1 2022 May 13, 2022	BUY	$8.64 - $11.71 $52,574 - $71,255	6,085 Added 15.76%	44,693 $387,000
Q3 2021 Nov 16, 2021	BUY	$12.95 - $18.24 $24,035 - $33,853	1,856 Added 5.05%	38,608 $500,000
Q1 2021 May 17, 2021	BUY	$15.92 - $20.3 $27,875 - $35,545	1,751 Added 5.0%	36,752 $632,000
Q3 2020 Nov 13, 2020	SELL	$13.97 - $21.16 $15,171 - $22,979	-1,086 Reduced 3.01%	35,001 $669,000
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $30,899 - $47,792	2,974 Added 8.98%	36,087 $495,000
Q1 2020 May 15, 2020	SELL	$8.89 - $24.94 $158,490 - $444,630	-17,828 Reduced 35.0%	33,113 $352,000
Q4 2019 Feb 07, 2020	BUY	$8.33 - $19.95 $43,116 - $103,261	5,176 Added 11.31%	50,941 $951,000
Q3 2019 Nov 08, 2019	BUY	$6.86 - $10.46 $34,526 - $52,645	5,033 Added 12.36%	45,765 $479,000
Q2 2019 Aug 09, 2019	BUY	$6.99 - $11.27 $284,716 - $459,049	40,732 New	40,732 $309,000
Q3 2018 Nov 13, 2018	SELL	$2.31 - $4.69 $116,599 - $236,732	-50,476 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$4.04 - $5.13 $152,037 - $193,057	-37,633 Reduced 42.71%	50,476 $227,000
Q1 2018 May 07, 2018	BUY	$3.92 - $5.35 $10,548 - $14,396	2,691 Added 3.15%	88,109 $472,000
Q4 2017 Jan 17, 2018	BUY	$3.9 - $4.66 $13,993 - $16,720	3,588 Added 4.38%	85,418 $337,000
Q3 2017 Nov 13, 2017	BUY	$4.14 - $5.12 $338,776 - $418,969	81,830	81,830 $358,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc X Biotech Inc. Transaction History